| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0008 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.002 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.76 | 0.004 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |